Levonest Kit
Product Images NDC 50090-2505

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Levonest (NDC 50090-2505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Chemical structures of the active ingredients levonorgestrel and ethinyl estradiol are shown side by side. Each structure depicts the molecular arrangement of atoms with appropriate bonds and functional groups clearly displayed.*

FDA Label Image

Image-02 (Image 02)

A boxed warning text panel highlighting the increased risk of serious cardiovascular side effects from oral contraceptive use associated with cigarette smoking, especially in women over 35 years of age or those smoking 15 or more cigarettes daily. It advises that women using oral contraceptives should be strongly advised not to smoke.*

FDA Label Image

Image-03 (Image 03)

A bar chart displaying circulatory disease mortality rates per 100,000 woman years categorized by age groups (15-24, 25-34, 35-44, 45+) and divided by smoking status and oral-contraceptive use. The chart compares ever-users and controls among both smokers and non-smokers, showing mortality rate variations primarily increasing with age.*

FDA Label Image

Image-04 (Image 04)

A warning text panel describing the increased risk of serious adverse effects on the heart and blood vessels associated with cigarette smoking while using oral contraceptives, especially in women over 35 years of age and those smoking 15 or more cigarettes per day. It advises women who use oral contraceptives not to smoke.*

FDA Label Image

Image-05 (Image 05)

A boxed warning text panel highlighting the increased risk of serious cardiovascular adverse effects from oral contraceptive use in women who smoke cigarettes, especially those over 35 years of age or who smoke 15 or more cigarettes per day, and advising that women using oral contraceptives should not smoke.*

FDA Label Image

Image-06 (Image 06)

Levonest kit containing a 4-week cycle of oral tablets with days of the week labeled SUN through SAT. Pills are color-coded as yellow, green, light brown, and white, arranged in rows by week numbers (Week 2, Week 3, Week 4). The label includes storage instructions to keep between 20°-25°C (68°-77°F) with some tablets placed in a specific sequence. The product is labeled by A-S Medication Solutions with NDC 50090-2505.*

FDA Label Image

Image-07 (Image 07)

An instructional illustration showing a hand placing a day-of-the-week label on a Levonest oral contraceptive kit blister pack. The diagram includes a guide to pick the correct day label (MON to SUN) and shows an example of the label aligned at the top of the blister pack containing different colored tablets arranged by week.*

FDA Label Image

Image-08 (Image 08)

FDA Label Image

Label Image (Lbl500902505)

Levonest kit by A-S Medication Solutions contains levonorgestrel and ethinyl estradiol tablets. The label lists active ingredients and strengths, package size of 28 tablets in a 7-day blister pack, and manufacturer information. It includes barcodes, an NDC number 50090-2505, and distribution details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.